K-numberK251484
Device nameCT:VQ
Applicant4Dmedical Limited
Product codeJAK
Device classClass II
Decision dateAug 28, 2025
DecisionSubstantially Equivalent
Regulation892.1750
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

CT:VQ is a software tool that analyzes paired inspiratory/expiratory chest CT scans to measure and visualize regional ventilation and perfusion in the lungs. It provides DICOM images and quantitative data to help radiologists, pulmonologists, and nuclear medicine physicians assess lung function and respiratory conditions in adult patients for clinical decision support without using contrast agents.

Technological characteristics

CT:VQ processes non-contrast paired chest CTs to derive ventilation and perfusion measures from lung tissue displacement, lung volume change, and Hounsfield Units. Unlike the primary predicate (CT:V, which measures only ventilation from non-contrast CTs), CT:VQ adds perfusion quantification. Unlike the secondary predicate (CSBP-001A, which requires contrast-enhanced dynamic CT), CT:VQ achieves both measurements from a single non-contrast acquisition.

Test standards cited

ANSI AAMI ISO14971:2019 (risk management), ISO62304:2006/Amendment 1:2016 (software life cycle), IEC62304-1:2016 (health software safety), IEEE 11073-40101/40102:2020 (cybersecurity), ISO14155:2020 (clinical investigation), ISO20417:2021 (labeling), and FDA guidance documents on device software and cybersecurity.

Substantial equivalence argument

CT:VQ is substantially equivalent because it shares the same regulatory classification (Class II, product code JAK), intended users (thoracic specialists), and patient population (adults) as the predicates. Functionally, it combines ventilation capability from the primary predicate (CT:V) with perfusion capability from the secondary predicate (CSBP-001A). Clinical studies demonstrated strong correlation with SPECT nuclear imaging and pulmonary function tests, showing CT:VQ outputs are interpretable and clinically actionable with a safety/effectiveness profile similar to the primary predicate, while providing contrast-free perfusion assessment.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →